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Background: During malaria infection, multiple pro-inflammatory mediators including IFN-γ, TNF and nitric oxide
(NO) play a crucial role in the protection against the parasites. Modulation of host immunity is an important
strategy to improve the outcome of malaria infection. Allicin is the major biologically active component of garlic
and shows anti-microbial activity. Allicin is also active against protozoan parasites including Plasmodium, which is
thought to be mediated by inhibiting cysteine proteases. In this study, the immunomodulatory activities of allicin
were assessed during acute malaria infection using a rodent malaria model Plasmodium yoelii 17XL.
Methods: To determine whether allicin modulates host immune responses against malaria infection, mice were
treated with allicin after infection with P. yoelii 17XL. Mortality was checked daily and parasitaemia was determined
every other day. Pro-inflammatory mediators and IL-4 were quantified by ELISA, while NO level was determined by
the Griess method. The populations of dendritic cells (DCs), macrophages, CD4+ T and regulatory T cells (Treg) were
assessed by FACS.
Results: Allicin reduced parasitaemia and prolonged survival of the host in a dose-dependent manner. This effect is
at least partially due to improved host immune responses. Results showed that allicin treatment enhanced the
production of pro-inflammatory mediators such as IFN-γ, TNF, IL-12p70 and NO. The absolute numbers of CD4+ T
cells, DCs and macrophages were significantly higher in allicin-treated mice. In addition, allicin promoted the
maturation of CD11c+ DCs, whereas it did not cause major changes in IL-4 and the level of anti-inflammatory
cytokine IL-10.
Conclusions: Allicin could partially protect host against P. yoelii 17XL through enhancement of the host innate and
adaptive immune responses.
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Malaria with its ~250 million clinical cases and a human
death toll of 0.9 million per year remains a huge prob-
lem in many tropical and subtropical countries [1]. To
realize the ambitious goal of malaria elimination, novel
integrated strategies are needed. Among them, vaccines
to reduce the morbidity and mortality associated with
malaria have been intensively pursued, but so far no
malaria vaccine is available. Vaccine development efforts* Correspondence: ymcao@mail.cmu.edu.cn
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reproduction in any medium, provided the orare thwarted partially by incomplete understanding of
the mechanisms of protective immunity against malaria,
which normally develops in populations residing in
hyperendemic areas after repeated exposure to malaria
infections.
To identify the key targets and mechanisms of protective
immunity against malaria, experimental murine malaria
models have significantly advanced our understanding of
how Plasmodium parasites interact with the host immune
responses in vivo [2]. It has become evident that Th1 type
pro-inflammatory immune responses are essential for
controlling the parasite load during the early phase of
infection [3-5]. Protective CD4+ T cells release IFN-γ tod. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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exert anti-malarial effects by releasing TNF and nitric
oxide (NO) [6,7]. NO can reduce parasitaemia during the
initial phase of blood-stage malaria infection [8,9]. During
malaria infection, regulatory T cells (Treg) can expand and
suppress the establishment of Th1 immune response [10],
resulting in increased parasitaemia and mortality of the
host [11,12]. Dendritic cells (DCs) are critical players in
innate immunity and priming T cell-dependent, specific
immune responses to malaria infection. DCs activated in
the spleen are major antigen-presenting cells (APCs), and
also a source of cytokines that help shape up cell-mediated
and humoral immunity [13,14]. Therefore, immunomodu-
latory drugs that improve the functions of DCs may lead to
enhanced immunity against malaria parasites.
Many natural products possess immunomodulatory
activities, which have long been sought for treating human
diseases. Garlic (Allium sativum) is one of the most
ancient vegetables and its medicinal uses are dated back
>5,000 years [15]. Garlic possesses evident pharmaco-
logical properties, such as antimicrobial [16,17], anti-
oxidant [18,19], and anticancer activities [20,21]. Garlic
and its components have potent antiparasitic activities
against many human and animal parasites [22], such as
Leishmania [23,24], Schistosoma [25,26], Trypanosoma,
Giardia, Entamoeba [27,28], and Plasmodium [29,30].
Allicin (diallyl thiosulfinate), rapidly converted from
allin by allinase in crushed fresh garlic cloves, is a major
component and thiosulphinate compound responsible for
the biological activity of garlic [31]. A recent study reported
that the potent anti-plasmodial and anti-trypanosomal
activity of allicin is associated with its inhibitory effect on
the cysteine proteases of the parasites [32]. In addition to
the proclaimed nutritional and antimicrobial effects [33],
garlic has immunomodulatory activities [15,34]. As an
immune stimulant, garlic components stimulate the pro-
liferation of splenocytes [34,35] and synthesis of NO and
TNF [36,37]. However, under certain circumstances, allicin
or garlic extract may also work as an immune suppressant
to down-regulate inflammatory responses and inhibit the
interaction of T cells with the endothelial cells [38].
Although the anti-parasitic effects of garlic extract and
allicin have been investigated, little is known about the
immunomodulatory effects of garlic on parasitic infec-
tions. In Leishmania major-infected susceptible mice,
treatment with garlic extract promoted the shift towards
a Th1 response and enhanced the phagocytic activity of
peritoneal macrophages, which significantly improved
the disease outcome [39,40]. Here, the murine malaria
model was used to investigate the effects of allicin on
the course of infection of BALB/c mice with the lethal
strain of Plasmodium yoelii 17XL. The results indicated
that allicin treatments promoted the production of pro-inflammatory mediators and protected the host from
Plasmodium infection.
Methods
Mice, parasite, and infection
Female, six to eight weeks old, BALB/c mice were
purchased from Academia Sinica Shanghai experimental
animal centre. Plasmodium yoelii 17XL infections were
initiated by intraperitoneal (IP) injection of 1 × 106 P. yoelii
17XL parasitized red blood cells (pRBCs) per mouse.
Parasitaemia was determined every other day by light
microscopic examination of at least 1,000 erythrocytes on
Giemsa-stained blood smears. Mortality was checked
daily. All experiments were performed in compliance with
local animal ethics committee requirements.
Allicin treatment
Allicin was purchased from Jinkongfu Pharmaceutical
(Wuhan, China). The stock solution was prepared by dis-
solving allicin in ethanol at a concentration of 10 mg/ml.
It was diluted to 1 mg/ml with phosphate buffered saline
(PBS) before use. For animal experiment, BALB/c mice
were randomly divided into three groups. Allicin was
orally administered by gavage at a dose of 3 or 9 mg/kg/day
on days 0–2 post-infection (PI). Mice in the control group
received 0.2 ml PBS at the same time points. Three mice in
each group were sacrificed on day 3 and 5, respectively.
The experiment was repeated three times.
Spleen cell culture and quantification of cytokines
Spleens from BALB/c mice were removed aseptically
and splenocytes were cultured as previously described
[41]. Splenocytes were adjusted to a final concentration
of 1 × 107 cells/ml in RPMI1640 supplemented with 10%
heat-inactivated foetal calf serum (FCS). Aliquots of
the cell suspension (5 × 106 cells/well) were seeded into
24-well, flat-bottom, tissue culture plates in triplicate,
and incubated for 48 hr at 37°C in a humidified 5%
CO2 incubator. The supernatants were collected and
stored at −80°C until assayed for cytokines.
Levels of IFN-γ, TNF, IL-12p70, IL-4 and IL-10 were
measured by commercial enzyme-linked immunosorbent
assay (ELISA) kits according to the manufacturer's
protocols (R&D Systems, Minneapolis, MN, USA). As a
measure of NO production, concentrations of NO2
- in
cell culture supernatants were determined by the Griess
reaction [42].
Flow cytometry
At the indicated time points, splenocytes were obtained
from infected BALB/c mice for flow cytometric analysis
to determine the subsets of spleen DCs: CD11c+CD11b+
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Figure 1 Effects of allicin treatment on parasitaemia and survival of P. yoelii 17XL infected mice. Mice were treated with two doses of
allicin (3 and 9 mg/kg) and PBS (control group) for successive three days after P. yoelii 17 XL infection. Parasitaemia was calculated by counting
the number of parasite-infected erythrocytes per 1,000 erythrocytes. Mortality was monitored daily. Results are presented as arithmetic mean of


































Figure 2 Serum levels of pro-inflammatory cytokines IFN-γ and
TNF. Sera were collected from allicin and PBS treated mice and the
amounts of IFN-γ (A) and TNF (B) were assayed by ELISA on day 0, 3
and 5 PI. There was no significant difference among groups by
Fisher’s LSD post-hoc test.
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expressing MHCII or TLR9, macrophages and Treg.
Antibodies and their sources were described previously
[41]. Flow cytometry was performed on a FACS Calibur
(BD Biosciences, San Diego, CA, USA) and analysed using
the FlowJo software (Treestar, San Carlos, CA, USA).
Statistical analysis
For each experiment, three mice were used to obtain an
average, and the average values from three experiments
were used to calculate the mean and standard error
(SEM). Statistical analysis was performed by one-way
ANOVA using the statistical software SPSS version
16.0. Fisher’s LSD post-hoc test was applied to assess
differences of each group. Time-to-event data were
statistically analysed with the Kaplan-Meier approach
to survival analysis using the statistical software SPSS
version 16.0. P values less than 0.05 were considered
statistically significant.
Results
Allicin improves survival by reducing parasitaemia
The P. yoelii 17XL strain is highly virulent to BALB/c
mice and causes lethal infection. In the control group,
parasitaemia rose sharply and reached a peak level
(51.8%) on day 5 PI (Figure 1A) and all mice died by day
7 (Figure 1B). In contrast, three-day oral allicin treat-
ments at two dosages significantly reduced the day 5
parasitaemias (27.1% and 32.6% for the 3 and 9 mg/kg
groups, respectively). Further decline of the parasitaemia
was noticed on day 7 PI in both allicin treatment groups
(Figure 1A). Consistent with an earlier observation on
the effect of allicin on Plasmodium berghei erythrocytic
infection [30], allicin treatments at both dosages signifi-
cantly extended the survival time of infected mice (P< 0.05
and P< 0.01 compared to NC group by Kaplan-Meier’s
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respectively (Figure 1B).
Allicin preferentially enhances pro-inflammatory
immune responses
As a cysteine protease inhibitor, the inhibitory effects of
allicin on Plasmodium parasites were attributed to the
direct action on parasites [30,32]. Because allicin also
has immunomodulatory activity, whether improved dis-
ease outcomes by allicin treatments could result from
strengthened host immunity against Plasmodium infection
was investigated. Previous studies have shown that enhance-
ment of Th1 responses during P. yoelii 17XL infection could
reduce the initial parasite load and extend host survival time
[43]. Here, the levels of several pro-inflammatory mediators
in the sera of control and allicin-treated mice were evalu-































































Figure 3 Effects of allicin on pro-inflammatory immune responses du
spleen cells were prepared and concentrations of IFN-γ (A), TNF (B), IL-12p
NO2
- (C) was detected using the Griess reaction.and treatment at 9 mg/kg increased TNF levels on both days
3 and 5 PI, although the differences were not statistically sig-
nificant (Figure 2). To further investigate whether the ele-
vated serum levels of pro-inflammatory cytokines were the
result of increased production in splenocytes, the in vitro
synthesis of IFN-γ, TNF, IL-12p70 and NO in cultured sple-
nocytes from the control and allicin-treated mice were mea-
sured. Compared to the control, allicin treatments at both
dosages caused significant increases in the production of
IFN-γ and TNF by splenocytes on days 3 and 5 PI (P<0.05)
and the effect appeared to be dose-dependent (Figure 3A,
B). More specifically, 9 mg/kg allicin treatment led to~
seven times higher production of IFN-γ than 3 mg/kg alli-
cin treatment on day 3 PI (Figure 3A). IFN-γ can promote
the production of NO by macrophages to reduce the para-
sitaemia during P. yoelii 17XL infection. Therefore, NO






























ring murine malaria infection. On day 0, 3 and 5 after infection,























































Figure 4 Effects of allicin treatments on CD4+ T cells and
macrophages during P. yoelii 17XL infection. Absolute numbers
of CD4+ T cells (A) and macrophages (B) were quantified by flow
cytometry at day 0, 3 and 5 PI. One experiment representative of
three is shown. Error bars represents SEM. Asterisks indicate
statistically significant differences (*: P < 0.05; **: P < 0.01) between
groups.
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earlier observation of other Th1 cytokines, both allicin
treatment dosages increased NO production on days 3
and 5 PI (Figure 3C). Yet, the 3 mg/kg treatment group
showed slight, insignificant increase of NO production as
compared to control (Figure 3C, P> 0.05). Significant in-
crease in NO2
- was evident in the higher dose (9 mg/kg) of
allicin treatment group (Figure 3C). IL-12 is an important
stimulator of the T-cell response and plays a critical role
in resistance to malaria [44-46]. Allicin treatments at both
dosages caused increases in the production of IL-12p70 by
splenocytes on days 3 and 5 PI and this effect also
appeared to be dose-dependent, albeit the difference was
not statistically significant (Figure 3D, P>0.05). To evalu-
ate whether allicin treatment affected Th2 immune re-
sponse during the early stage of P. yoelii 17XL infection,
the amount of IL-4 in the supernatant of cultured spleno-
cytes was determined, and there was no significant differ-
ence between the experiment and control groups
(Figure 3E, P>0.05). Altogether, these results showed that
allicin treatment preferentially promoted the production of
pro-inflammatory mediators during acute malaria infection
in a dose-dependent manner.
Allicin treatments stimulate expansion of CD4+ T cells
and macrophages
Protective immunity against blood-stage Plasmodium
requires malaria-specific CD4+ T cells to rapidly and
effectively control parasitaemia and clear the infection
[47]. In addition, macrophages also play an essential role
for parasite control during the early acute phase infec-
tion by the lethal P. yoelii strain [9]. Whereas significant
changes in the number of CD4+ T cells in both allicin
treatment groups on day 3 PI were observed, spleen
CD4+ T cell expansion was detected on day 5 PI
(Figure 4A). Again, this change in spleen CD4+ T cell
was only evident in the 9 mg/kg allicin-treated group.
Similarly, mice treated with 9 mg/kg of allicin had
significantly more macrophages in the spleen than either
control or 3 mg/kg allicin-treated mice (Figure 4B).
Allicin treatments promote the activation of
dendritic cells
DCs are the critical link between innate and adaptive
immune responses. Two subpopulations of DCs are
defined as mDCs (CD11c+CD11b+) and pDCs (CD11c+
CD45R/B220+). On day 3 PI, the numbers of mDCs
were not significantly different between the allicin
treatment groups and control (Figure 5A). However,
9 mg/kg allicin significantly suppressed the total num-
ber of spleen pDCs (Figure 5B). On day 5 PI, allicin
treatment at 3 mg/kg produced more mDCs and pDCs,
albeit the increases were not statistically significant. In
comparison, the numbers of both DC populations onday 5 PI in the 9 mg/kg allicin treatment group were
significantly higher than those in the control or 3 mg/kg
allicin treatment groups (Figure 5A, B).
Maturation of DCs is essential to induce Th1 immune
response for antigen presentation to T cells [48]. To
study whether allicin treatment had any effect on activa-
tion of DCs, the numbers of DCs expressing MHCII and
TLR9 between the control and treatment groups were
compared. Infection with P. yoelii 17XL significantly
increased the total numbers of mature DCs expressing
MHC II on day 3 PI, but no significant difference was
observed among the treatment groups (Figure 5C). On
day 5 PI, however, 9 mg/kg allicin treatment group
produced significantly more MHC II-expressing DCs
than control (P< 0.05) or 3 mg/kg allicin treatment group
(P< 0.01) (Figure 5C). Analysis of TLR9-expressing DCs

































































































Figure 5 Effects of allicin treatments on DCs during P. yoelii 17XL infection. Representative graphs show the absolute numbers of cells in
the spleens for (A) mDCs, (B) pDCs, and (C) CD11c+ MHCII+ DCs, (D) CD11c+ TLR9+ DCs on day 0, 3, and 5 PI. The cells were quantified by flow
cytometry analysis and data presented as the mean± standard error (n = 3 mice/group). Results are representative of three independent
experiments. Error bars represents SEM. Asterisks indicate statistically significant differences (*: P < 0.05; **: P <0.01) between groups.
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allicin treatment at 9 mg/kg promoted expansion of
matured DCs and enhanced TLR9-mediated innate immune
activation on day 5 during P. yoelii 17XL infection.
Allicin has no effect on IL-10 production or Treg
The immunomodulatory functions of allicin can also
down-regulate the inflammatory response [49-51]. The
effect of allicin treatment on Treg, which has an inhibi-
tory effect on Th1 immune response, and the anti-
inflammatory cytokine IL-10 was examined. Only allicin
treatment at 9 mg/kg significantly increased the absolute
numbers of Treg on day 5 PI as compared to both
control mice and 3 mg/kg allicin-treated mice (Figure 6A).
However, the serum levels of IL-10 were not significantly
different between the control and allicin-treated group on
either day 3 or day 5 PI (Figure 6B). Similarly, the produc-
tion of IL-10 by cultured splenocytes was not significantly
different between the control and allicin-treated groups
(Figure 6C).
Discussion
Allicin, a sulphur compound produced in garlic, has
antibacterial, antifungal and antiparasitic activities. The
main mechanism and mode of action of allicin isgenerally considered to be its reaction with the SH
group on cysteine residues of enzymes in the pathogens,
resulting in their inactivation [52,53]. The antiparasitic
activity of allicin on Plasmodium and Trypanosoma was
attributed to the inhibition of cysteine proteases in these
parasites [32]. Previous studies have shown that allicin
inhibited P. berghei circumsporozoite protein processing
and prevented sporozoite invasion of host cells in vitro
as well as protected the P. berghei-infected mice from
early death [30,54]. This study assessed the immunomo-
dulatory effect of allicin on P. yoelii 17XL-infected mice.
The results showed the anti-malarial activity of allicin in
P. yoelii 17XL infected mice was partially due to its
enhancement of the pro-inflammatory immune response
by expanding the populations of CD4+ T cells, mDCs
and macrophages as well as stimulating DCs maturation.
Pro-inflammatory mediators play an important role in
controlling parasitaemia at the early stage during P. yoelii
17XL infection [6,11,55,56]. Expansion of macrophages
and elevated TNF level are critical for controlling para-
sitaemia [57], while IFN-γ forms a central mediator of
protective immune responses against pre-erythrocytic
and blood-stage malaria parasites [58]. During the acute
phase of malaria infection, native T cells may be stimu-






















































Figure 6 Effects of allicin treatments on Treg and IL-10 level
during P. yoelii 17XL infection. (A) Absolute numbers of Treg at
various time points as detected by flow cytometry analysis. (B) The
concentrations of IL-10 in sera on day 3 and 5 PI. (C) The
concentrations of IL-10 produced by cultured splenocytes.
Concentrations of IL-10 were determined by ELISA. Data expressed
as the mean with SEM (n = 3 mice per group). Results are
representative of three independent experiments. Asterisks indicate
statistically significant differences (**: P < 0.01) between groups.
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mediators (IFN-γ, TNF and NO) in a dose-dependent
manner in P. yoelii 17XL-infected BALB/c mice, con-
sistent with allicin’s function as an immune stimulant
[34-37]. To a lower extent, allicin treatment also
enhanced the production of IL-12p70 of cultured spleen
cells, another indicator for enhanced Th1 response.
Finally, allicin treatment stimulated expansion of CD4+ T
cells, which further supports the activation of Th1 im-
mune response. As a hallmark of Th2 immune response,
IL-4 level in allicin treated mice was comparable to that in
control mice, indicating that allicin treatment did not
affect Th2 immune response during early P. yoelii 17XL
infection.
DCs bridge the innate and adaptive immune response
as APCs via antigen presentation to helper T cells, which
can activate native T cells and polarize CD4+ T cells
response [60]. Stimulation of T-cell responses, and more
importantly, induction of Th1 cell development, is asso-
ciated with maturation of DCs as well as their production
of Th1 cytokines [61,62]. Thus, the strategy to improve
the maturation and activation of DCs is key to the initi-
ation of a protective immune response against malaria
infection. The results suggested that allicin treatment
could significantly promote the maturation of DCs with
increasing expression of the co-stimulatory molecules.
Toll like receptors (TLRs) expressed on the innate
immune cells (such as DCs) engaged in the recognition
of constituents of protozoan parasites [63,64]. Upon
TLR-driven activation, DCs produce pro-inflammatory and
protective cytokines that contribute to innate immunity.
TLR9 mediates innate immune activation by the malaria
haemozoin [65] and protein-DNA complex [66]. TLR9
mediates parasite recognition and initiates IFN-γ produc-
tion to prime host innate responses against malaria [67,68].
In summary, allicin could expand the population of TLR9-
expressing DCs, resulting in increases of the IFN-γ level.
Another aspect of allicin’s immunomodulatory effect is
down-regulation of pro-inflammatory response. Allicin
could reduce the TNF level in a dose-dependent manner
and suppress both spontaneous and TNF stimulated
secretion of cytokines IL-1, IL-6 and IL-8 [38,69]. This is
largely due to regulation of the host Treg and anti-
inflammatory cytokine IL-10. Depletion of Treg protects
BALB/c mice infected with P. yoelii 17XL from over-
whelming parasitaemia and death [70]. Therefore, Treg
provide an essential mechanism for the parasites to evade
host-mediated immunity. In addition, TLR9 engagement
in DCs is required for natural Treg activation by malaria
parasites [71]. The higher dose of allicin treatment
increased the TLR9 expression on DCs on day 5 PI, which
in turn increased the number of Treg. However, the level
of IL-10 was not correspondently elevated, suggesting that
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Treg during the acute malaria infection.
In summary, allicin treatment can protect host against
malaria infection by activating pro-inflammatory immune
responses in a dose-dependent manner. The immune-
stimulatory effect of allicin is characterized by induced
mature DCs during early phase of P. yoelii 17XL infection,
which leads to increased levels of pro-inflammatory
mediators from proliferative macrophages and CD4+ T cells.
The results provide important insights into the in vivo
parasite-inhibitory mechanism of allicin, which suggests
the involvement of both direct inhibition of parasite
enzymes and stimulation of antiparasitic immune response
of the host.
Conclusions
Allicin treatment could enhance host immunity against
malaria infection in a rodent malaria model. It was
observed that treatment with allicin during P. yoelii
17XL infection could enhance host innate and adaptive
immunity evidenced by elevated numbers of macrophages
and CD4+ T cells and cytokines. In addition, allicin treat-
ment promoted the expansion and maturation of DCs,
which play an essential role in initiating adaptive im-
munity. However, the function of Treg was not altered
by allicin treatment. Collective findings from this study
suggest that allicin partially protects host against malaria
infection through enhancement of the host’s innate and
adaptive immune responses.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YF carried out the flow cytometry, statistical analysis and drafted the
manuscript. XZ performed detection of cytokines and NO2
- concentration. YJ
and HS helped to revise the manuscript. YC and LC conceived the study and
participated in the design of the study. All authors read and approved the
final manuscript.
Acknowledgements
This work was supported by grants from the National Natural Science
Foundation of China (30800962).
Author details
1Department of Immunology, College of Basic Medical Sciences, China
Medical University, Shenyang, Liaoning, China. 2Department of Laboratory
Medicine, the First Hospital of China Medical University, Shenyang, Liaoning,
China. 3The Key Laboratory of AIDS Immunology of Ministry of Health, the
First Hospital of China Medical University, Shenyang, Liaoning, China.
4Department of Entomology, Pennsylvania State University, University Park,
PA, USA.
Received: 6 May 2012 Accepted: 22 July 2012
Published: 8 August 2012
References
1. WHO: World Malaria Report 2009. Geneva: World Health Organization; 2010.
2. Wykes MN, Good MF: What have we learnt from mouse models for the
study of malaria? Eur J Immunol 2009, 39:2004–2007.3. Stevenson MM, Riley EM: Innate immunity to malaria. Nat Rev Immunol
2004, 4:169–180.
4. Schofield L, Grau GE: Immunological processes in malaria pathogenesis.
Nat Rev Immunol 2005, 5:722–735.
5. Urban BC, Ing R, Stevenson MM: Early interactions between blood-stage
Plasmodium parasites and the immune system. Curr Top Microbiol
Immunol 2005, 297:25–70.
6. Amante FH, Good MF: Prolonged Th1-like response generated by a
Plasmodium yoelii-specific T cell clone allows complete clearance of
infection in reconstituted mice. Parasite Immunol 1997, 19:111–126.
7. Wang R, Charoenvit Y, Corradin G, De La Vega P, Franke ED, Hoffman SL:
Protection against malaria by Plasmodium yoelii sporozoite surface
protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-
dependent elimination of infected hepatocytes. J Immunol 1996,
157:4061–4067.
8. Awasthi A, Kumar A, Upadhyay SN, Yamada T, Matsunaga Y: Nitric oxide
protects against chloroquine resistant Plasmodium yoelii nigeriensis
parasites in vitro. Exp Parasitol 2003, 105:184–191.
9. Couper KN, Blount DG, Hafalla JC, van Rooijen N, de Souza JB, Riley EM:
Macrophage-mediated but gamma interferon-independent innate
immune responses control the primary wave of Plasmodium yoelii
parasitemia. Infect Immun 2007, 75:5806–5818.
10. Cambos M, Belanger B, Jacques A, Roulet A, Scorza T: Natural regulatory
(CD4+CD25+FOXP3+) T cells control the production of pro-inflammatory
cytokines during Plasmodium chabaudi adami infection and do not
contribute to immune evasion. Int J Parasitol 2008, 38:229–238.
11. Wu Y, Wang QH, Zheng L, Feng H, Liu J, Ma SH, Cao YM: Plasmodium yoelii:
distinct CD4(+)CD25(+) regulatory T cell responses during the early
stages of infection in susceptible and resistant mice. Exp Parasitol 2007,
115:301–304.
12. Bueno LL, Morais CG, Araujo FF, Gomes JA, Correa-Oliveira R, Soares IS,
Lacerda MV, Fujiwara RT, Braga EM: Plasmodium vivax: induction of
CD4+ CD25+ FoxP3+ regulatory T cells during infection are directly
associated with level of circulating parasites. PLoS One 2010, 5:e9623.
13. Steinman RM, Hemmi H: Dendritic cells: translating innate to adaptive
immunity. Curr Top Microbiol Immunol 2006, 311:17–58.
14. Manicassamy S, Pulendran B: Modulation of adaptive immunity with Toll-
like receptors. Semin Immunol 2009, 21:185–193.
15. Butt MS, Sultan MT, Butt MS, Iqbal J: Garlic: nature's protection against
physiological threats. Crit Rev Food Sci Nutr 2009, 49:538–551.
16. Goncagul G, Ayaz E: Antimicrobial effect of garlic (Allium sativum). Recent
Pat Antiinfect Drug Discov 2010, 5:91–93.
17. Ankri S, Mirelman D: Antimicrobial properties of allicin from garlic.
Microbes Infect 1999, 1:125–129.
18. Ramoutar RR, Brumaghim JL: Antioxidant and anticancer properties and
mechanisms of inorganic selenium, oxo-sulfur, and oxo-selenium
compounds. Cell Biochem Biophys 2010, 58:1–23.
19. Sun X, Ku DD: Allicin in garlic protects against coronary endothelial
dysfunction and right heart hypertrophy in pulmonary hypertensive rats.
Am J Physiol Heart Circ Physiol 2006, 291:H2431–H2438.
20. Antony ML, Singh SV: Molecular mechanisms and targets of cancer
chemoprevention by garlic-derived bioactive compound diallyl trisulfide.
Indian J Exp Biol 2011, 49:805–816.
21. Nagini S: Cancer chemoprevention by garlic and its organosulfur
compounds-panacea or promise? Anticancer Agents Med Chem 2008,
8:313–321.
22. Anthony JP, Fyfe L, Smith H: Plant active components - a resource for
antiparasitic agents? Trends Parasitol 2005, 21:462–468.
23. Wabwoba BW, Anjili CO, Ngeiywa MM, Ngure PK, Kigondu EM, Ingonga J,
Makwali J: Experimental chemotherapy with Allium sativum (Liliaceae)
methanolic extract in rodents infected with Leishmania major and
Leishmania donovani. J Vector Borne Dis 2010, 47:160–167.
24. Gamboa-Leon MR, Aranda-Gonzalez I, Mut-Martin M, Garcia-Miss MR,
Dumonteil E: In vivo and in vitro control of Leishmania mexicana due to
garlic-induced NO production. Scand J Immunol 2007, 66:508–514.
25. Mantawy MM, Ali HF, Rizk MZ: Therapeutic effects of Allium sativum and
Allium cepa in Schistosoma mansoni experimental infection. Rev Inst Med
Trop São Paulo 2011, 53:155–163.
26. Nahed HA, Hoda AT, Yomna IM: Effects of garlic on albino mice
experimentally infected with Schistosoma mansoni: a parasitological and
ultrastructural study. Trop Biomed 2009, 26:40–50.
Feng et al. Malaria Journal 2012, 11:268 Page 9 of 9
http://www.malariajournal.com/content/11/1/26827. Lun ZR, Burri C, Menzinger M, Kaminsky R: Antiparasitic activity of diallyl
trisulfide (Dasuansu) on human and animal pathogenic protozoa
(Trypanosoma sp., Entamoeba histolytica and Giardia lamblia) in vitro.
Ann Soc Belg Med Trop 1994, 74:51–59.
28. Ankri S, Miron T, Rabinkov A, Wilchek M, Mirelman D: Allicin from garlic
strongly inhibits cysteine proteinases and cytopathic effects of
Entamoeba histolytica. Antimicrob Agents Chemother 1997, 41:2286–2288.
29. Perez HA, De la Rosa M, Apitz R: In vivo activity of ajoene against rodent
malaria. Antimicrob Agents Chemother 1994, 38:337–339.
30. Coppi A, Cabinian M, Mirelman D, Sinnis P: Antimalarial activity of allicin, a
biologically active compound from garlic cloves. Antimicrob Agents
Chemother 2006, 50:1731–1737.
31. Amagase H: Clarifying the real bioactive constituents of garlic. J Nutr
2006, 136:716S–725S.
32. Waag T, Gelhaus C, Rath J, Stich A, Leippe M, Schirmeister T: Allicin and
derivates are cysteine protease inhibitors with antiparasitic activity.
Bioorg Med Chem Lett 2010, 20:5541–5543.
33. Amagase H, Petesch BL, Matsuura H, Kasuga S, Itakura Y: Intake of garlic
and its bioactive components. J Nutr 2001, 131:955S–962S.
34. Kyo E, Uda N, Kasuga S, Itakura Y: Immunomodulatory effects of aged
garlic extract. J Nutr 2001, 131:1075S–1079S.
35. Lau BH, Yamasaki T, Gridley DS: Garlic compounds modulate macrophage
and T-lymphocyte functions. Mol Biother 1991, 3:103–107.
36. Bhattacharyya M, Girish GV, Karmohapatra SK, Samad SA, Sinha AK: Systemic
production of IFN-alpha by garlic (Allium sativum) in humans. J Interferon
Cytokine Res 2007, 27:377–382.
37. Morihara N, Sumioka I, Moriguchi T, Uda N, Kyo E: Aged garlic extract
enhances production of nitric oxide. Life Sci 2002, 71:509–517.
38. Hodge G, Hodge S, Han P: Allium sativum (garlic) suppresses leukocyte
inflammatory cytokine production in vitro: potential therapeutic use in the
treatment of inflammatory bowel disease. Cytometry 2002, 48:209–215.
39. Ghazanfari T, Hassan ZM, Ebtekar M, Ahmadiani A, Naderi G, Azar A: Garlic
induces a shift in cytokine pattern in Leishmania major-infected BALB/c
mice. Scand J Immunol 2000, 52:491–495.
40. Ghazanfari T, Hassan ZM, Khamesipour A: Enhancement of peritoneal
macrophage phagocytic activity against Leishmania major by garlic
(Allium sativum) treatment. J Ethnopharmacol 2006, 103:333–337.
41. Zhu X, Pan Y, Zheng L, Cui L, Cao Y: Polysaccharides from the Chinese
medicinal herb Achyranthes bidentata enhance anti-malarial immunity
during Plasmodium yoelii 17XL infection in mice. Malar J 2012, 11:49.
42. Cao YM, Tsuboi T, Torii M: Nitric oxide inhibits the development of
Plasmodium yoelii gametocytes into gametes. Parasitol Int 1998, 47:157–166.
43. Zhou LD, Zhang QH, Zhang Y, Liu J, Cao YM: The shiitake mushroom-
derived immuno-stimulant lentinan protects against murine malaria
blood-stage infection by evoking adaptive immune-responses. Int
Immunopharmacol 2009, 9:455–462.
44. Sedegah M, Finkelman F, Hoffman SL: Interleukin 12 induction of
interferon gamma-dependent protection against malaria. Proc Natl Acad
Sci U S A 1994, 91:10700–10702.
45. Doolan DL, Hoffman SL: IL-12 and NK cells are required for antigen-
specific adaptive immunity against malaria initiated by CD8+ T cells in
the Plasmodium yoelii model. J Immunol 1999, 163:884–892.
46. Su Z, Stevenson MM: IL-12 is required for antibody-mediated protective
immunity against blood-stage Plasmodium chabaudi AS malaria infection
in mice. J Immunol 2002, 168:1348–1355.
47. Stephens R, Albano FR, Quin S, Pascal BJ, Harrison V, Stockinger B, Kioussis
D, Weltzien HU, Langhorne J: Malaria-specific transgenic CD4(+) T cells
protect immunodeficient mice from lethal infection and demonstrate
requirement for a protective threshold of antibody production for
parasite clearance. Blood 2005, 106:1676–1684.
48. Ing R, Segura M, Thawani N, Tam M, Stevenson MM: Interaction of mouse
dendritic cells and malaria-infected erythrocytes: uptake, maturation,
and antigen presentation. J Immunol 2006, 176:441–450.
49. Schwartz IF, Hershkovitz R, Iaina A, Gnessin E, Wollman Y, Chernichowski T,
Blum M, Levo Y, Schwartz D: Garlic attenuates nitric oxide production in
rat cardiac myocytes through inhibition of inducible nitric oxide
synthase and the arginine transporter CAT-2 (cationic amino acid
transporter-2). Clin Sci (Lond) 2002, 102:487–493.
50. Hasan N, Yusuf N, Toossi Z, Islam N: Suppression of Mycobacterium
tuberculosis induced reactive oxygen species (ROS) and TNF-alpha mRNA
expression in human monocytes by allicin. FEBS Lett 2006, 580:2517–2522.51. Bruck R, Aeed H, Brazovsky E, Noor T, Hershkoviz R: Allicin, the active
component of garlic, prevents immune-mediated, concanavalin A-
induced hepatic injury in mice. Liver Int 2005, 25:613–621.
52. Kyung KH: Antimicrobial properties of allium species. Curr Opin Biotechnol
2012, 23:142–147.
53. Fujisawa H, Watanabe K, Suma K, Origuchi K, Matsufuji H, Seki T, Ariga T:
Antibacterial potential of garlic-derived allicin and its cancellation by
sulfhydryl compounds. Biosci Biotechnol Biochem 2009, 73:1948–1955.
54. Rennenberg A, Lehmann C, Heitmann A, Witt T, Hansen G, Nagarajan K,
Deschermeier C, Turk V, Hilgenfeld R, Heussler VT: Exoerythrocytic
Plasmodium parasites secrete a cysteine protease inhibitor involved in
sporozoite invasion and capable of blocking cell death of host
hepatocytes. PLoS Pathog 2010, 6:e1000825.
55. Chen G, Feng H, Liu J, Qi ZM, Wu Y, Guo SY, Li DM, Wang JC, Cao YM:
Characterization of immune responses to single or mixed infections with
P. yoelii 17XL and P. chabaudi AS in different strains of mice. Parasitol Int
2010, 59:400–406.
56. Taylor-Robinson AW, Phillips RS, Severn A, Moncada S, Liew FY: The role of TH1
and TH2 cells in a rodent malaria infection. Science 1993, 260:1931–1934.
57. Taverne J, Sheikh N, de Souza JB, Playfair JH, Probert L, Kollias G: Anaemia
and resistance to malaria in transgenic mice expressing human tumour
necrosis factor. Immunology 1994, 82:397–403.
58. McCall MB, Sauerwein RW: Interferon-gamma–central mediator of
protective immune responses against the pre-erythrocytic and blood
stage of malaria. J Leukoc Biol 2010, 88:1131–1143.
59. Perry JA, Rush A, Wilson RJ, Olver CS, Avery AC: Dendritic cells from malaria-
infected mice are fully functional APC. J Immunol 2004, 172:475–482.
60. Banchereau J, Steinman RM: Dendritic cells and the control of immunity.
Nature 1998, 392:245–252.
61. Wykes MN, Liu XQ, Beattie L, Stanisic DI, Stacey KJ, Smyth MJ, Thomas R,
Good MF: Plasmodium strain determines dendritic cell function essential
for survival from malaria. PLoS Pathog 2007, 3:e96.
62. Ing R, Stevenson MM: Dendritic cell and NK cell reciprocal cross talk
promotes gamma interferon-dependent immunity to blood-stage
Plasmodium chabaudi AS infection in mice. Infect Immun 2009, 77:770–782.
63. Iwasaki A, Medzhitov R: Toll-like receptor control of the adaptive immune
responses. Nat Immunol 2004, 5:987–995.
64. Pasare C, Medzhitov R: Toll-like receptors: linking innate and adaptive
immunity. Adv Exp Med Biol 2005, 560:11–18.
65. Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, Uematsu S, Yamamoto M,
Takeuchi O, Itagaki S, Kumar N, Horii T, Akira S: Toll-like receptor 9
mediates innate immune activation by the malaria pigment hemozoin. J
Exp Med 2005, 201:19–25.
66. Wu X, Gowda NM, Kumar S, Gowda DC: Protein-DNA complex is the
exclusive malaria parasite component that activates dendritic cells and
triggers innate immune responses. J Immunol 2010, 184:4338–4348.
67. Kalis C, Gumenscheimer M, Freudenberg N, Tchaptchet S, Fejer G, Heit A,
Akira S, Galanos C, Freudenberg MA: Requirement for TLR9 in the
immunomodulatory activity of Propionibacterium acnes. J Immunol 2005,
174:4295–4300.
68. Franklin BS, Parroche P, Ataide MA, Lauw F, Ropert C, de Oliveira RB, Pereira
D, Tada MS, Nogueira P, da Silva LH, Bjorkbacka H, Golenbock DT, Gazzinelli
RT: Malaria primes the innate immune response due to interferon-
gamma induced enhancement of toll-like receptor expression and
function. Proc Natl Acad Sci U S A 2009, 106:5789–5794.
69. Lang A, Lahav M, Sakhnini E, Barshack I, Fidder HH, Avidan B, Bardan E,
Hershkoviz R, Bar-Meir S, Chowers Y: Allicin inhibits spontaneous and TNF-
alpha induced secretion of proinflammatory cytokines and chemokines
from intestinal epithelial cells. Clin Nutr 2004, 23:1199–1208.
70. Hisaeda H, Maekawa Y, Iwakawa D, Okada H, Himeno K, Kishihara K,
Tsukumo S, Yasutomo K: Escape of malaria parasites from host immunity
requires CD4+ CD25+ regulatory T cells. Nat Med 2004, 10:29–30.
71. Hisaeda H, Tetsutani K, Imai T, Moriya C, Tu L, Hamano S, Duan X, Chou B,
Ishida H, Aramaki A, Shen J, Ishii KJ, Coban C, Akira S, Takeda K, Yasutomo K,
Torii M, Himeno K: Malaria parasites require TLR9 signaling for immune
evasion by activating regulatory T cells. J Immunol 2008, 180:2496–2503.
doi:10.1186/1475-2875-11-268
Cite this article as: Feng et al.: Allicin enhances host pro-inflammatory
immune responses and protects against acute murine malaria infection.
Malaria Journal 2012 11:268.
